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Ataxia telangiectasia (AT) is a rare neurodegenerative disorder, inherited in an autosomal recessive manner. Total blood samples
were collected from 20 patients with AT, 13 parents of patients, and 17 healthy volunteers. This study aimed at evaluating the
frequency of chromosomal breaks in spontaneous cultures, induced by bleomycin and ionizing radiation, and further evaluated
the rates of oxidative stress in AT patients and in their parents, compared to a control group. Three cell cultures were performed
to each individual: the first culture did not receive induction to chromosomal instability, the second was exposed to bleomycin,
and the last culture was exposed to ionizing radiation. To evaluate the rates of oxidative stress, the markers superoxide dismutase
(SOD), catalase (CAT), and thiobarbituric acid (TBARS) were utilized. Significant differences were observed between the three
kinds of culture treatments (spontaneous, bleomycin, and radiation induced) and the breaks and chromosomal aberrations in the
different groups. The oxidative stress showed no significant differences between the markers. This study showed that techniques
of chromosomal instability after the induction of ionizing radiation and bleomycin are efficient in the identification of syndrome
patients, with the ionizing radiation being the most effective.
1. Introduction
Ataxia telangiectasia (AT) is a rare neurodegenerative dis-
order, autosomal recessive inherited [1, 2]. The carriers are
apparently born normal; however, by 2-3 years old, clinical
manifestations appear. The frequency of occurrence of the
syndrome in the United States is approximately one in 40,000
live births [3].
Ataxic movements and ocular telangiectasia are among
the pathologicalmanifestations [4–7]. AT syndrome is caused
by a mutation in the gene located on chromosome 11q22-23
encoding the protein ATM kinase [2, 8]. ATM recognizes
double-stranded breaks in DNA and signals the cell-cycle
checkpoints [2].
AT patients are sensitive to ionizing radiation [9, 10] and
have chromosomal instability, defects in cell-cycle check-
points [2, 11], and, therefore, increased risk of developing
cardiovascular disease and cancer [6, 12]. Hypersensitivity
and chromosomal instability characteristic of AT patients can
be evaluated through the high frequency of chromosomal
breaks and gaps, rearrangements, aneuploidy, and transloca-
tions [13–15] observed in cells spontaneous carriers [16] or
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in cells exposed to mutagens [13–15]. Furthermore, patients
with AT exhibit high rates of chromosomal rearrangements
involving autosomal chromosomes 7 and 14. Changes are
often found as translocations and inversions involving these
chromosomes [17].
Chronic oxidative stress is a common feature of AT
[14, 18], but the involvement of ATM protein or the degree
of oxidative stress is not elucidated. Bleomycin is already
widely used in the evaluation of chromosomal instability in
patients with clinical suspicion of AT, but is rarely used as
a supplementary examination or routine for the parents of
these patients. Based on this, the present work is to provide
important information to incorporate new routine tests in
identifying patients with AT. Early identification of these is
of paramount importance for prenatal counseling, diagnosis,
improvement or insertion and treatments for the various
manifestations of the disease.The early diagnosis ofATwould
help in the prevention of cancer, where there is an increased
frequency of this disease among patients and their parents.
In this sense, the present study evaluated the frequency
of spontaneous, radiation-induced and bleomycin-induced
chromosome breakage, as well as the level of oxidative stress
in AT patients and parents of patients with the syndrome by
comparing the results with the control group.
2. Materials and Methods
2.1. Patients and Blood Sampling. This study was developed
at the Cytogenetics Laboratory from the Medical Genetics
Service of the Hospital de Cĺınicas de Porto Alegre, Brazil,
between August 2011 and June 2012. We evaluated the chro-
mosomal instability and oxidative stress in blood cells sam-
pled from 20AT patients, aged 15.3± 10.2 years and 13 parents
aged 41.0 ± 10.6 years of the AT patients. The control group
was composed of 17 healthy individuals aged 22.4± 13.4 years.
Subjects were enrolled after signing an informed consent
term in accordance with the guidelines of the Ethics Com-
mittee at Hospital de Cĺınicas de Porto Alegre (HCPA), RS,
Brazil. Ten-milliliter samples of heparinized peripheral blood
were collected, immediately protected from light, and stored
at 4∘C for evaluation. All subjects answered the personal
health questionnaire of theCommission for Protection Against
Environmental Mutagens and Carcinogens (ICPEMC).
2.2. Cell Cultures, Treatments, and Chromosome Preparations.
For the chromosomal instability analysis, three cell cultures
were performed to each individual included in this study. A
protocol adapted from 1960 [19] was used. Slides were stained
with GTG-banding technique [20].
The first culture did not receive induction to chro-
mosomal instability, thereby representing the spontaneous
cultures of each individual. The second culture was exposed
to bleomycin (6 𝜇g/mL of culture). The third culture was
exposed to 3Gy (ionizing radiation from a 137Cs 𝛾-ray
source). The irradiation was performed at the Gamma Cell
1000 Elite irradiator.
The breaks and chromosomal aberrations observed in
the three treatments of all individuals groups were reported.
A minimum of 4 and a maximum of 50 metaphases made by
culture were analysed, depending on the cell growth of each
culture. Chromosomal aberrations were classified as chro-
matid breaks (chtb), chromosome breaks (chrb), chromo-
some fragments, translocations (t), deletions (del), interstitial
deletions, dicentric chromosomes, triradial and quadriradial
figures, Rings chromosome (r), Additional materials (add),
isochromosomes (iso), chromatid failures (chtg), chromoso-
mal failures (chrg), and fragile sites.
To calculate the frequency of chromosomal instability
flaws and fragile sites were excluded, because they are not
considered chromosome breakage. The other changes were
included in the count, and the number of breaks for each
occurrence of each chromosome abnormality observed was
recorded.
2.3. Definition of Chromosomal Changes. The chromosome
breaks are defined as all discontinuities in the chromosome
that are experiencing a greater distance than the width of a
chromatid, which may involve one (chtb) or both chromatids
(chrb) breaks giving rise to acentric chromosome fragments
[21].The translocations are formedwhen there is an exchange
of portions of two or more chromosomes [22]. Deletions are
characterized by the loss of a portion of a chromosome.These
deletions can be terminal (del) or interstitial (interstitial dele-
tion). Interstitial deletions are defined when there is loss of a
middle segment of the chromosome [22]. The chromosomes
are dicentric chromosomes with two centromeres. They are
formed from two chromosomes break and union portions
of centromere [22]. The figures are chromosomal rearrange-
ments involving more than one chromosome and more than
one break point, which can be classified as either triradial or
quadriradial [23]. The chromosomal rings are formed when
there is loss of telomeric portions of chromosomes resulting
from the union of edges forming a circular chromosome [22].
Additional materials of unknown origin were classified as
add. These additional materials can be formed by insertion,
duplication, or translocation of chromosome segments [22].
Isochromosome is formed when a loss occurs in a portion
of the chromosome and the other portion is doubled [22].
Failures chromatid and chromosomal are defined as all
discontinuities in one (chtg) or both chromatids (chrg) of
chromosomes that have a distance less than one chromatid
[21]. The fragile sites are regions where there is abnormal
chromatin compaction [24].They are viewed as a glitch in the
chromosome.
2.4. Oxidative Stress. For preparation of the samples, 5mL
of whole blood was collected from each patient. The samples
were centrifuged for 5minutes at a speed of 3000 RPM. After
centrifugation, plasma was separated from red blood cells
using a disposable Pasteur pipette. The plasma was stored in
an Eppendorf.
Red blood cells were centrifuged for 5minutes at a speed
of 3000 RPM and washed three times with saline solution.
After washing, the red blood was collected and stored in a
1.5mL Eppendorf with a buffer prepared with magnesium
sulfate (MgSO
4
) and acetic acid. The Eppendorf ’s plasma
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Table 1: Frequency of chromosomal breaks observed in the different groups and treatments.
Frequency of chromosomal breaks
Spontaneous Bleomycin (6𝜇g/mL) Radiation (3Gy)
Patients
Frequency (min ×max) 0.00–1.30 0.43–5.65 0.47–7.32
𝜒 frequencies/cell 0.18 1.63 2.10
𝑁
∘ cells (min ×max) 30 × 50 30 × 50 30 × 50
Parents
Frequency (min ×max) 0.00–0.13 0.00–1.27 0.23–0.93
𝜒 frequencies/cell 0.02 0.56 0.52
𝑁
∘ cells (min ×max) 30 × 50 5 × 50 21 × 50
Control group
Frequency (min ×max) 0.00–0.03 0.00–0.90 0.10–0.93
𝜒 frequencies/cell 0.01 0.47 0.56
𝑁
∘ cells (min ×max) 30 4 × 30 13 × 30
𝜒: average frequency of chromosomal breaks per cell.
and red blood cells were stored in a freezer at −80∘C until
processing.
To assess oxidative stress, markers TBARS (thiobarbituric
acid), SOD (superoxide dismutase), and CAT (catalase) were
used.
2.5. Measure of Substances That React in TBARS. The tech-
nique of TBARS is the sample heating with thiobarbituric
acid and the consequent formation of a colored product,
measured in a spectrophotometer at 535 nm.The occurrence
of staining is due to the presence of Malondialdehyde (MDA:
an indicator of oxidative stress) and other substances from
lipid peroxidation in biological material. Plasma samples
were placed in test tubes with 0.75mL of trichloroacetic acid
(TCA) 10%, 0.25mL of homogenate, 0.5mL of thiobarbituric
acid (TBARS) 0.67%, and 25mL of distilled water. The
tubes were stirred and heated to a temperature of 100∘C.
After the tubes were cooled, 1.5mL of n-butyl alcohol was
added, to extract the pigment formed. After that the samples
were placed in a shaker (Biomatic) for 45 seconds and
centrifuged for 10minutes at 3000 RPM (1110×g). Finally, the
colored product was removed and read in spectrophotometer
(CARY 3E-UV-Visible Spectrophotometer Varian) with a
wavelength of 535 nm.The concentration of TBARS obtained
was expressed in ng per mg total protein [25, 26].
2.6. Evaluation of the Activity of CAT. The rate of decom-
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maximum absorbance. An incubation mixture containing a
final volume of 1000 𝜇L with reagents was prepared: 50mM




. In quartz cuvette,
955 𝜇L phosphate buffer and 25 𝜇L plasmawere added, which
were placed in the apparatus and minus the blank. 20𝜇L of
hydrogen peroxide was added and readings were performed
at 240 nm. The results were expressed as pmoles/g tissue per
mg total protein [26, 27].
Table 2: Statistical analysis comparing the frequency of breaks of
different treatments for each group.




Patients a a, b b 0.006
Parents a b b 0.001
Control
group a b b 0.000
Treatments with at least one letter in common exhibit similar frequency of
breaks (𝛼 = 0.05).
2.7. Evaluation of the Activity of SOD. The technique for
determination of SOD, second Misra and Fridovich [28], is
based on inhibition of the formation of superoxide dismu-
tase in adrenochrome autoxidation of epinephrine. Whereas
epinephrine remains stable in acidic solutions and sponta-
neously oxidizes in basic solutions, favoring the formation
of adrenochrome, SOD can be measured spectrophotomet-
rically by following the change in absorbance at 480 nm of
epinephrine which has a peak absorbance. To perform the
reaction, a mixture was prepared with a final volume of
1mL with bicarbonate buffer (0.05M, pH 10.2) and plasma
epinephrine (4mM). The absorbance used was 480 nm,
at 30∘C. The line pattern was developed with increasing
concentrations of SOD (20–100 nM) to determine the con-
centration that produces the same whether the inhibition of
autoxidation of epinephrine by 50%, and the results were
expressed as USOD/mg of total protein. An enzyme activity
is defined as the amount of enzyme which is able to inhibit
50% of autoxidation of epinephrine [26].
2.8. Quantification of Total Protein. For the quantification
of total protein, the method of Bradford [29] was used.
The Bradford method is a technique for determining total
protein using the Coomassie Brilliant Blue dye BG-250. This
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Table 3: Statistical analysis comparing the chromosomal aberrations (CAs) between the different groups within each treatment.












































































∗demonstrates the chromosomal aberrations with statistically significant differences.
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method is based on the interaction between the dye BG-250
proteins and macromolecules containing amino acids basic
side chains or aromatic amino acids. In the reaction pH,
the interaction between the protein and the high molecular
weight dye BG-250 causes the displacement of the equilib-
rium to form anionic dye, which absorbs strongly at 595 nm
in a spectrophotometer [30].
2.9. Statistical Analysis. To evaluate the difference of the
frequencies of chromosomal breaks between the different
treatments (Spontaneous, bleomycin, and radiation) in each
group (patients, parents, or controls) the Friedman test was
used.
Statistical analysis of chromosomal abnormalities and
total number of breaks between different groups and treat-
ments were performed using the Kruskal-Wallis test. The
correlation between total chromosomebreakage anddifferent
oxidative stress markers was performed using the Spearman
test. When statistical analysis showed significant results,
post hoc Bonferroni correction was concucted. Multiple
comparisons were performed with SPSS, version 15.0, with a
significance level of 0.05.
3. Results and Discussion
The sample number and analyzed cells varied depending on
the difficulty of each individual cell growth. The rates of cell
growth were variable among individuals sampled and from
culture to culture. Overall, we observed a sharp decline in
growth in the cultures of the group of patients among the
three treatments, as described next. Cell growth failure was
observed: in patients: 45% samples included in spontaneous
and radiation treatments, and 50% samples on treatment
with Bleomycin; in parents: 7.7% samples in spontaneous and
radiation treatments, and 23.08% in the sample on treatment
with Bleomycin and in controls: 23.53% samples in treating
spontaneous and 11.76% in the treatment with radiation and
Bleomycin.
Regarding the frequency of chromosome breakage, the
average of those in the spontaneous treatment of patientswith
AT demonstrated to be increased compared to the control
group, as shown in Table 1. In relation to treatment with
induction of DNA damage, patients with AT demonstrated
hypersensitivity to the effects of bleomycin and ionizing
radiation compared to the control group, confirming what
has been described by Huo et al. [9], Sun et al. [10], Abraham
[31], and Barzilai et al. [32] (Table 1). Hypersensitivity for
bleomycin was demonstrated to be about three times higher
than that recorded in the parent groups and controls. Already,
hypersensitivity to ionizing radiation proved to be about four
times higher in the group of patients than that observed in
the groups of parents and controls.
The average frequency of chromosome breakage in par-
ents was almost similar to that obtained by the control group,
showing no significant differences as observed in the study by
Sun et al. [10] (Table 1).
Statistically, the frequency of chromosomal breaks
observed in the three treatments showed significant differ-
ences (𝛼 = 0.05) in patients, parents, and controls, as shown
Table 4: Statistical analysis comparing the total number of breaks
in each treatment between the different groups.
Treatments Groups 𝑃 value of theKruskal-Wallis test
Patients Parents Controlgroup
Spontaneous a a, b b 0.007
Bleomycin
(6𝜇g/mL) a b b 0.001
Radiation
(3Gy) a b b 0.001
Treatments with at least one letter in common exhibit similar number of
breaks (𝛼 = 0.05).
in Table 2, and in the breaks and chromosomal aberrations
in the different groups (Table 3). Increased rearrangements
were not observed involving the chromosomes 7 and 14.
Statistically, the total number of breaks in each of
the different treatment groups showed significant differ-
ences (Table 4). In spontaneous treatment, differences were
observed between patients and controls, and for treatment
with bleomycin and radiation, such differenceswere observed
between patients and parents and between patients and
controls (Table 4).
No significant differences were observed between differ-
ent markers of oxidative stress, as shown in Table 5.
The correlation analysis between the total number of
breaks of the spontaneous treatment in each group relative to
each index marker of oxidative stress showed no significant
differences, as shown in Table 6.
A factor that may have influenced the growth of these
cultures was the amount of DNA damage generated after
induction with bleomycin and radiation. The damage caused
to the DNA interferes with their replication, triggering
mutations, various types of chromosomal abnormalities, or
cell death by apoptosis [33]. Formicroscopic analysis, cells are
stationed inmetaphase by the use of colchicine—in this stage,
the cells have been through the process of repairing damage
(G
2
phase), where cells that have undergone higher levels of
DNA damage are eliminated via apoptosis. Gilad et al. [34]
showed that ionizing radiation inhibited cell growth in the 6
patients whowere included in the study, proving the difficulty
of cell growth in patients with the syndrome.
The variation in the amount of cells analyzed for each
patient may have influenced the low rates of chromosomal
rearrangements involving chromosomes 7 and 14 in patients
with AT observed. It was then possible to observe that
the evaluation techniques of chromosomal instability after
exposure to ionizing radiation or bleomycin are effective
in identifying patients with the syndrome, and ionizing
radiation was considered the most effective.
Prospects are expected to increase the sample size to
conduct further sampling of patients and standardizing the
number of cells analyzed. A much more detailed analysis of
each patient was developed in order to make more accurate
assessments by chromosomal abnormalities and indices of
oxidative stress. The inclusion of the analysis of the marker
of oxidative stress glutathione peroxidase (GPx) is also
6 BioMed Research International







𝜒 Patients 3.36 1.11 21.16
𝜒 Parents 3.03 0.95 27.04
𝜒 Control
group 3.42 0.73 20.79
𝜒: average indices of oxidative stress observed.
Table 6: Correlation of the total number of spontaneous breaks of
treatment of each group in relation to indexes of different markers
of oxidative stress.
Groups Markers of oxidative stress
TBARS CAT SOD
Patients 0.774 0.518 0.200 𝑃 value of the
Spearman
correlation
Parents 1.000 0.809 0.499
Control group 0.222 0.223 0.631
(𝛼 = 0.05).
expected. The GPx develops its role in situations where there
are low levels of hydrogen peroxide, while CAT operates in
situations of high concentrations [35, 36].Therefore, with the
inclusion of this marker and with the addition of a larger
number of patients, it will be possible to measure reliably
whether or not this happening oxidative stress is strong
evidence in patients with AT.
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